Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
Abstract
All sleep studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchSleepSleep (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 39% Improvement Relative Risk Hospitalization 32% Case 7% Sleep for COVID-19  Jones et al.  Prophylaxis Is better sleep beneficial for COVID-19? Retrospective study in multiple countries Lower mortality (p=0.001) and hospitalization (p<0.0001) c19early.org Jones et al., Sleep Medicine, July 2022 Favors good sleep Favors control

Public health impact of poor sleep on COVID-19, influenza and upper respiratory infections

Jones et al., Sleep Medicine, doi:10.1016/j.sleep.2022.05.369
Jul 2022  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
FinnGen Mendelian randomization study showing higher risk of COVID-19 mortality, hospitalization, and infection with insomnia.
risk of death, 39.0% lower, OR 0.61, p = 0.001, inverted to make OR<1 favor higher quality sleep, RR approximated with OR.
risk of hospitalization, 32.0% lower, OR 0.68, p < 0.001, inverted to make OR<1 favor higher quality sleep, RR approximated with OR.
risk of case, 7.4% lower, OR 0.93, p = 0.04, inverted to make OR<1 favor higher quality sleep, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Jones et al., 21 Jul 2022, retrospective, multiple countries, peer-reviewed, 12 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperSleepAll
PUBLIC HEALTH IMPACT OF POOR SLEEP ON COVID-19, INFLUENZA AND UPPER RESPIRATORY INFECTIONS
S E Jones, F I Maisha, S Strausz, B Cade, A Tervi, V Helaakoski, M Broberg, V Lammi, J M Lane, S Redline, R Saxena, H M Ollila, L S Castro, L Baraças, G Hashioka, C Bonadio, H Hachul, R Santos-Silva, D Poyares
there were significant differences in the ASRS (t¼-6.175, p<0.001), WURS (t¼-6.087, p<0.01), p<0.001), p<0.001), p<0.01). Psychological characteristics differed significantly in ASRS (F¼22.517, p<0.001, aIn comparison of the insomnia-positive group to the insomnia-negative group, the OR was 4.088 in the PHQ-9 positive group (95% CI: 2.02-8.28) and 2.286 in the MDQ positive group (95% CI: 1.38-2.86). Conclusions: Insomnia was associated with a variety of mental symptoms, and the psychological symptoms were shown to be severe according to the severity of insomnia. Therefore, adequate intervention is needed to improve the symptoms of insomnia.
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit